Patent US5089343A successfully refreshed from Google Patents.
US5089343A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Curable dielectric polyphenylene ether-polyepoxide compositions
Assignee: SABIC Global Technologies BV
•
Filing: 1989-08-03
•
Granted: 1992-02-18
•
Expires: 2009-08-03
Abstract
Abstract Curable polyphenylene ether-polyepoxide compositions containing 1-methylimidazole as the primary curing catalyst have improved latency properties and are useful in the preparation of laminates and bonding sheets for printed circuit boards.
Inventors
- 👤 Robert E. Colborn
- 👤 James R. Presley
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 19:36
CPC Classifications
C; C08; C08L; C08L63/00; C08G; C08G59/00; C08G59/18; C08G59/40; C08G59/68; C08G59/686; C08L71/00; C08L71/08; C08L71/10; C08L71/12; C08L71/123; C08L83/00; C08L83/04; H; H05; H05K; H05K1/00; H05K1/02; H05K1/03; H05K1/0313; H05K1/032; H05K1/0326; Y; Y10; Y10S; Y10S428/00; Y10S428/901; Y10S428/913; Y10T; Y10T428/00; Y10T428/24; Y10T428/24802; Y10T428/29; Y10T428/2913; Y10T428/2933; Y10T428/294; Y10T428/2942; Y10T428/2949; Y10T428/31504; Y10T428/31511; Y10T428/31515; Y10T428/31518; Y10T428/31522; Y10T428/31551; Y10T428/31627; Y10T428/31678; Y10T428/31688
Claims Analysis
Total Claims: 41
Claim 1
Independent Claim
62 words
A curable article comprising a fibrous substrate impregnated with a curable polyphenylene ether-polyepoxide composition comprising: (I) about 20 to about 80% of at least one polyphenylene ether; (II) about 80 to about 20% of at least one polyepoxide compound; (III) a catalytically effective amount of 1-methylimidazole; and (IV) a cocatalytically effective amount of zinc or aluminum in the form of a salt.
Claim 2
Dependent Claim
62 words
A curable article comprising a fibrous substrate impregnated with a curable polyphenylene ether-polyepoxide composition comprising: (I) about 20 to about 80% of at least one polyphenylene ether; (II) about 80 to about 20% of at least one polyepoxide compound; (III) a catalytically effective amount of 1-methylimidazole; and (IV) a cocatalytically effective amount of zinc or aluminum in the form of a salt.
Claim 3
Dependent Claim
26 words
The curable article according to claim 1 wherein component I is a poly(2,6-dimethyl-1,4-phenylene ether) having a number average molecular weight within the range of about 3000-40,000.
Claim 4
Dependent Claim
22 words
The curable article according to claim 1 wherein component (II) contains chemically combined bromine in an amount effective to impart flame retardancy.
Claim 5
Dependent Claim
31 words
The curable article according to claim 3 wherein component (II) contains about 5 to about 50% by weight chemically combined bromine based on the total amounts of components (I) and (II).
Claim 6
Dependent Claim
95 words
The curable article according to claim 4 wherein component (II) comprises at least one bisphenol polyglycidyl ether having an average of at most one aliphatic hydroxy group per molecule, the composition containing about 5 to about 50% by weight bromine as aryl substituents, and comprising compounds having the formula ##STR11## wherein m is 0-4 and n has an average value up to 1, each of A 1 and A 2 is a monocyclic divalent aromatic radical and Y is a bridging radical in which one or two atoms separate A 1 from A 2 .
Claim 7
Dependent Claim
23 words
The curable article according to claim 5 wherein A 1 and A 2 are both p-phenylene radicals, and Y is an isopropylidene radical.
Claim 8
Dependent Claim
99 words
The curable article according to claim 1 wherein component (II) comprises the reaction product obtained by heating at a temperature in the range of about 125-225° C., in the presence of a catalytic amount of at least one basic reagent, a mixture comprising: (A) at least one halogen-free bisphenol polyglycidyl ether having an average of at most one aliphatic hydroxy group per molecule; and (B) about 5 to about 40% of at least one bisphenol containing bromine as aryl substituents, the percentage of reagent (B) being by weight and based on the total amounts of reagents (A) and (B).
Claim 9
Dependent Claim
29 words
The curable article according to claim 7 wherein reagent (A) has the formula ##STR12## wherein n has an average value up to 1 and reagent (B) is tetrabromobisphenol A.
Claim 10
Dependent Claim
17 words
The curable article according to claim 8 wherein n is about 0.14 and reagent (B) is 2,2-bis(3,5-dibromo-4-hydroxyphenyl)propane.
Claim 11
Dependent Claim
31 words
The curable article according to claim 9 wherein the amount of reagent (B) is about 20 to about 30% by weight based on the total amounts of reagents (A) and (B).
Claim 12
Dependent Claim
36 words
The curable article according to claim 7 further comprising (C) about 0 to about 30% of at least one halogen-free epoxidized novolak, the percentage being by weight and based on total reagents (A), (B), and (C).
Claim 13
Dependent Claim
19 words
The curable article according to claim 11 wherein reagent (C) is a novolak prepared from formaldehyde, phenol, and epichlorohydrin.
Claim 14
Dependent Claim
35 words
The curable article according to claim 1 wherein component (III) is present in an amount sufficient to provide a total of at least 5 milliequivalents of basic nitrogen per 100 parts of the curable composition.
Claim 15
Dependent Claim
35 words
The curable article according to claim 13 wherein component (III) is present in an amount sufficient to provide a total of at least 20 milliequivalents of basic nitrogen per 100 parts of the curable composition.
Claim 16
Dependent Claim
17 words
The curable article according to claim 1 wherein component (III) further comprises at least one aromatic polyamine.
Claim 17
Dependent Claim
37 words
The curable article according to claim 15 wherein the aromatic polyamine is present in component (III) in the amount of about 60 to about 70% by weight based on the total amount of 1-methylimidazole and aromatic polyamine.
Claim 18
Dependent Claim
23 words
The curable article according to claim 16 wherein the aromatic polyamine is a 3,5-diethyl-substituted 2,4-diaminotoluene or a 3,5-diethyl-substituted 2,6-diaminotoluene or a mixture thereof.
Claim 19
Dependent Claim
64 words
The curable article according to claim 17 wherein component (III) further comprises a substituted guanidine compound having the formula ##STR13## wherein Z 1 and Z 3 independently represent a lower alkyl group having about 1-4 carbon atoms or a substituted monovalent aromatic compound; and Z 2 , Z 4 and Z 5 independently represent hydrogen or a lower alkyl group having about 1-carbon atoms.
Claim 20
Dependent Claim
18 words
The curable article according to claim 18 wherein the substituted guanidine compound is represented by the formula: ##STR14##
Claim 21
Dependent Claim
39 words
The curable article according to claim 19 wherein the substituted guanidine compound is present in component (III) in the amount of about 20 to about 80% by weight based on the total amount of 1-methylimidazole and substituted guanidine compound.
Claim 22
Dependent Claim
32 words
The curable article according to claim 1 wherein zinc or aluminum salt of component (IV) is about 2 to about 8%, the salt being soluble or stably dispersible in the curable composition.
Claim 23
Dependent Claim
16 words
The curable article according to claim 1 wherein component (IV) is zinc acetylacetonate or zinc stearate.
Claim 24
Dependent Claim
32 words
The curable article according to claim 1 further comprising (V) at least one halogen-free novolak in the amount of about 3 to about 20% by weight based on the total curable composition.
Claim 25
Dependent Claim
19 words
The curable article according to claim 23 wherein component (V) is a novolak prepared from formaldehyde, phenol, and epichlorohydrin.
Claim 26
Dependent Claim
48 words
The curable article according to claim 1 further comprising (VI) at least one halogen-free novolak, substantially all oxygen therein being in the form of phenolic hydroxy groups, the novolak being present in the amount of about 0 to about 20% by weight based on the total curable composition.
Claim 27
Dependent Claim
79 words
The curable article according to claim 1 further comprising at least one aliphatic tris(dialkylphosphato)-titanate of the formula ##STR15## wherein Y 1 is C 2-6 primary or secondarily alkyl or alkenyl, Y 2 is C 1-3 alkylene, Y 3 is C 1-5 primary or secondary alkyl, Y 4 is C 5-12 primary or secondary alkyl and a is from 0 to about 3, in the amount of about 0 to about 1% by weight based on the total curable composition.
Claim 28
Dependent Claim
30 words
The curable article according to claim 26 wherein Y 1 is alkyl, Y 2 is methyl, Y 3 is ethyl, Y 4 is octyl and a is 0 or 1.
Claim 29
Dependent Claim
32 words
The curable article according to claim 1 further comprising about 0 to about 5% of antimony oxide stably dispersed therein, the percentage being by weight and based on the total curable composition.
Claim 30
Dependent Claim
102 words
A curable article comprising a fibrous substrate impregnated with a curable polyphenylene-polyepoxide composition having improved latency and comprising: (I) about 20 to about 80% of at least one polyphenylene ether; (II) about 80 to about 20% of at least one polyepoxide compound; (III) 1-methylimidazole in an amount sufficient to provide a total of at least 5 milliequivalents of basic nitrogen per 100 parts of said curable composition, said composition being dissolved in an effective amount of 1-methylimidazole; and (IV) about 2 to about 8% of zinc in the form of a salt which is soluble or stably dispersible in said curable composition.
Claim 31
Dependent Claim
102 words
A curable article comprising a fibrous substrate impregnated with a curable polyphenylene-polyepoxide composition having improved latency and comprising: (I) about 20 to about 80% of at least one polyphenylene ether; (II) about 80 to about 20% of at least one polyepoxide compound; (III) 1-methylimidazole in an amount sufficient to provide a total of at least 5 milliequivalents of basic nitrogen per 100 parts of said curable composition, said composition being dissolved in an effective amount of 1-methylimidazole; and (IV) about 2 to about 8% of zinc in the form of a salt which is soluble or stably dispersible in said curable composition.
Claim 32
Dependent Claim
12 words
The article according to claim 1 wherein the substrate is glass fiber.
Claim 33
Dependent Claim
12 words
The article according to claim 29 wherein the substrate is glass fiber.
Claim 34
Dependent Claim
17 words
A cured article prepared by the application of heat and pressure to the article of claim 30.
Claim 35
Dependent Claim
17 words
A cured article prepared by the application of heat and pressure to the article of claim 31.
Claim 36
Dependent Claim
17 words
A printed circuit board plank comprising an article according to claim 32 clad with a conductive metal.
Claim 37
Dependent Claim
14 words
The printed circuit board blank according to claim 34 wherein the metal is copper.
Claim 38
Dependent Claim
17 words
A printed circuit board plank comprising an article according to claim 33 clad with a conductive metal.
Claim 39
Dependent Claim
14 words
The printed circuit board blank according to claim 36 wherein the metal is copper.
Claim 40
Dependent Claim
30 words
A multilayer circuit assembly comprising at least two printed circuit boards separated by a cured composition prepared by the application of heat and pressure to the article of claim 1.
Claim 41
Dependent Claim
30 words
A multilayer circuit assembly comprising at least two printed circuit boards separated by a cured composition prepared by the application of heat and pressure to the article of claim 29.
References Cited (Backward Citations)
US3306875A
Cited
US3306874A
Cited
US3257357A
Cited
US3257358A
Cited
US3367978A
Cited
US4066625A
Cited
JPS49107100A
Cited
US3914266A
Cited
US4028341A
Cited
US4054553A
Cited
US4092294A
Cited
US4234706A
Cited
US4431779A
Cited
US4517341A
Cited
US4521584A
Cited
US4482697A
Cited
US4477649A
Cited
US4477651A
Cited
US4853423A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-02-17 | 1995-08-19 | 1996-02-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-02-17 | 1999-08-19 | 2000-02-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-02-17 | 2003-08-19 | 2004-02-18 | $7700.00 | Window Closed / Lapsed |